Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on ¹⁸F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer.

ABSTRACT:

Purpose

Prostate specific membrane antigen targeted ¹⁸F-DCFPyL positron emission tomography/computerized tomography may offer superior image quality and sensitivity for the detection of biochemically recurrent prostate cancer. We examined the association of Gleason sum, serum prostate specific antigen and prostate specific antigen doubling time with any detectable and pelvic confined disease in patients with biochemically recurrent prostate cancer.

Materials and methods

Data from 108 patients with biochemically recurrent prostate cancer after radical prostatectomy who underwent prostate specific membrane antigen targeted ¹⁸F-DCFPyL positron emission tomography/computerized tomography were analyzed. Data were collected on positive positron emission tomog

SUBMITTER: Markowski MC 

PROVIDER: S-EPMC7945885 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature